[1] MAKRAS P,ANASTASILAKIS A D. Bone disease in primary hyperparathyroidism[J].Metabolism,2018,80: 57-65.
[2] BILEZIKIAN J P, BANDEIRA L, KHAN A,et al. Hyperparathyroidism[J].Lancet,2018,391(10116):168-178.
[3] GUILMETTE J, SADOW P M. Parathyroid pathology[J].Surg Pathol Clin,2019,12(4):1007-1019.
[4] WILHELM S M, WANG T S, RUAN D T, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism[J].JAMA Surg,2016,151(10):959-968.
[5] BILEZIKIAN J P. Primary hyperparathyroidism[J].J Clin Endocrinol Metab,2018,103(11):3993-4004.
[6] CHEN J, CAO J, QIU F, et al. The Efficacy and The safety of ultrasound-guided ablation therapy for treating papillary thyroid microcarcinoma[J].J Cancer,2019,10(21):5272-5282.
[7] HA E J, BAEK J H, BAEK S M. Minimally invasive treatment for benign parathyroid lesions: Treatment efficacy and safety based on nodule characteristics[J].Korean J Radiol,2020,21(12):1383-1392.
[8] PAPINI E, MONPEYSSEN H, FRASOLDATI A,et al. 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules[J].Eur Thyroid J,2020,9(4):172-185.
[9] BAEK J H, LEE J H, VALCAVI R,et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser[J].Korean J Radiol,2011,12(5):525-540.
[10] DUC N M, KESERCI B. Emerging clinical applications of high-intensity focused ultrasound[J].Diagn Interv Radiol,2019,25(5):398-409.
[11] SANDHU A, NGUYEN D T. Forging ahead: Update on radiofrequency ablation technology and techniques[J].J Cardiovasc Electrophysiol,2020,31(1):360-369.
[12] HUSSAIN I, AHMAD S, ALJAMMAL J. Radiofrequency ablation of parathyroid adenoma: A novel treatment option for primary hyperparathyroidism[J].AACE Clin Case Rep,2021,7(3):195-199.
[13] SORMAZ I C, POYANLI A, AÇAR S,et al. The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible [J].Cardiovasc Intervent Radiol,2017,40(4):596-602.
[14] FAN B Q, HE X W, CHEN H H, et al.US-guided microwave ablation for primary hyperparathyroidism: A safety and efficacy study[J].Eur Radiol,2019,29(10):5607-5616.
[15] LIU C, WU B, HUANG P, et al. US-Guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: feasibility and safety study[J].J Vasc Interv Radiol,2016,27(6):867-875.
[16] BENNEDBAEK F N, KARSTRUP S, HEGEDÜS L. Ultrasound guided laser ablation of a parathyroid adenoma[J].Br J Radiol,2001,74(886):905-907.
[17] JIANG T A, CHEN F, ZHOU X, et al. Percutaneous ultrasound-guided laser ablation with contrast-enhanced ultrasonography for hyperfunctioning parathyroid adenoma: A preliminary case series[J].Int J Endocrinol,2015,2015:673604.
[18] KOVATCHEVA R D, VLAHOV J D, SHINKOV A D, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: A feasibility study in four patients[J].AJR Am J Roentgenol,2010,195(4):830-835.
[19] KOVATCHEVA R, VLAHOV J, STOINOV J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism[J].Eur Radiol,2014,24(9):2052-2058.
[20] BEER E. Removal of neoplasms of the urinary bladder: A new method, employing high-frequency (oudin) currents through a catheterizing cystoscope[J].Am J Med,1952,13(5):542-543.
[21] NI W J, YUAN Y, CHU X Q, et al. Bone turnover markers in response to ultrasound-guided microwave ablation for primary hyperparathyroidism[J].Front Endocrinol (Lausanne),2021,12:782050.
[22] ANDRIOLI M, RIGANTI F, PACELLA C M, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: Present and future perspectives[J].AJR Am J Roentgenol,2012,199(5):1164-1168.
[23] LIU F Y, YU X L, Liu Z L, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism[J].Int J Hyperthermia,2019,36(1):835-840.
[24] DUC N M, KESERCI B. Emerging clinical applications of high-intensity focused ultrasound[J].Diagn Interv Radiol,2019,25(5):398-409. |